$INGN
Inogen Inc Stock $ingn

$ingn Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000156459016027375 Filed on November 03, 2016

Income Statement

Concept	2016 Q3	2015 Q4	2015 Q3
Revenue	$54.40M	$40.45M	$40.78M
YoY Change	33.41%	38.9%	38.73%
Cost Of Revenue	$29.30M	$20.40M	$16.05M
YoY Change	82.6%	33.33%	8.83%
Gross Profit	$25.10M	$20.04M	$19.38M
YoY Change	29.55%	45.03%	32.26%
Gross Profit Margin	46.14%	49.54%	47.51%
Selling, General & Admin	$18.40M	$15.30M	$14.55M
YoY Change	26.5%	30.77%	41.43%
% of Gross Profit	73.31%	76.35%	75.07%
Research & Development	$1.400M	$1.200M	$1.116M
YoY Change	25.45%	71.43%	39.85%
% of Gross Profit	5.58%	5.99%	5.76%
Depreciation & Amortization	$3.420M	$3.540M	$3.560M
YoY Change	-3.93%	7.27%	13.09%
% of Gross Profit	13.63%	17.67%	18.37%
Operating Expenses	$19.70M	$16.60M	$15.66M
YoY Change	25.79%	33.87%	41.32%
Operating Profit	$5.400M	$3.438M	$3.714M
YoY Change	45.4%	142.8%	4.12%
Interest Expense	$100.0K	$0.00	$5.000K
YoY Change	1900.0%		-95.19%
% of Operating Profit	1.85%	0.0%	0.13%
Other Income/Expense, Net	$0.00	-$200.0K	-$36.00K
YoY Change	-100.0%	100.0%	-61.29%
Pretax Income	$5.449M	$3.317M	$3.678M
YoY Change	48.15%	155.15%	5.87%
Income Tax	$203.0K	-$541.0K	$982.0K
% Of Pretax Income	3.73%	-16.31%	26.7%
Net Earnings	$5.246M	$3.858M	$2.696M
YoY Change	94.58%	153.98%	26.39%
Net Earnings / Revenue	9.64%	9.54%	6.61%
Basic Earnings Per Share	$0.26	$0.20	$0.14
Diluted Earnings Per Share	$0.25	$0.19	$0.13
COMMON SHARES
Basic Shares Outstanding	20.16M	19.69M	19.43M
Diluted Shares Outstanding	21.18M	20.81M	20.78M

Balance Sheet

Concept	2016 Q3	2015 Q4	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$108.3M	$82.90M	$74.10M
YoY Change	46.15%	45.95%	31.85%
Cash & Equivalents	$86.01M	$66.11M	$55.10M
Short-Term Investments	$22.30M	$16.79M	$19.00M
Other Short-Term Assets	$1.900M	$1.300M	$7.900M
YoY Change	-75.95%	-80.3%	1.28%
Inventory	$16.50M	$8.648M	$9.400M
Prepaid Expenses
Receivables	$29.70M	$19.87M	$20.90M
Other Receivables	$1.600M	$2.100M	$2.200M
Total Short-Term Assets	$158.1M	$114.8M	$114.4M
YoY Change	38.2%	24.1%	28.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.80M	$30.68M	$31.70M
YoY Change	-15.46%	-3.91%	1.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.600M	$97.00K	$11.10M
YoY Change	-13.51%	0.0%	-32.73%
Total Long-Term Assets	$53.21M	$46.47M	$43.10M
YoY Change	23.47%	-2.25%	-10.02%
TOTAL ASSETS
Total Short-Term Assets	$158.1M	$114.8M	$114.4M
Total Long-Term Assets	$53.21M	$46.47M	$43.10M
Total Assets	$211.3M	$161.3M	$157.5M
YoY Change	34.17%	15.15%	14.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.21M	$7.448M	$14.30M
YoY Change	-28.57%	10.97%	27.68%
Accrued Expenses	$8.800M	$5.300M	$4.600M
YoY Change	91.3%	29.27%	24.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K	$315.0K	$311.0K
YoY Change	-67.85%	5.35%	16.48%
Total Short-Term Liabilities	$30.20M	$22.01M	$22.84M
YoY Change	32.24%	17.5%	11.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$80.00K
YoY Change	-100.0%	-100.0%	-79.54%
Other Long-Term Liabilities	$8.500M	$337.0K	$321.0K
YoY Change	2547.98%	-10.13%	-86.63%
Total Long-Term Liabilities	$8.500M	$337.0K	$401.0K
YoY Change	2019.7%	-51.16%	2.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.20M	$22.01M	$22.84M
Total Long-Term Liabilities	$8.500M	$337.0K	$401.0K
Total Liabilities	$38.70M	$27.30M	$27.55M
YoY Change	40.48%	24.44%	18.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.62M	-$45.11M	-$48.97M
YoY Change	-64.01%	-20.43%	-15.88%
Common Stock		$179.2M	$178.9M
YoY Change		2.47%	993722.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$172.6M	$134.0M	$129.9M
YoY Change
Total Liabilities & Shareholders Equity	$194.8M	$161.3M	$157.5M
YoY Change	23.71%	15.15%	14.81%

Cashflow Statement

Concept	2016 Q3	2015 Q4	2015 Q3
OPERATING ACTIVITIES
Net Income	$5.246M	$3.858M	$2.696M
YoY Change	94.58%	153.98%	26.39%
Depreciation, Depletion And Amortization	$3.420M	$3.540M	$3.560M
YoY Change	-3.93%	7.27%	13.09%
Cash From Operating Activities	$9.050M	$12.56M	$11.85M
YoY Change	-23.63%	190.07%	269.16%
INVESTING ACTIVITIES
Capital Expenditures	-$370.0K	-$400.0K	-$560.0K
YoY Change	-33.93%	-23.08%	21.74%
Acquisitions
YoY Change
Other Investing Activities	-$10.32M	-$70.00K	-$6.250M
YoY Change	65.12%	-98.4%	84.91%
Cash From Investing Activities	-$10.69M	-$480.0K	-$6.820M
YoY Change	56.74%	-90.14%	77.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.080M	-1.100M	-1.770M
YoY Change	-274.01%	-190.16%	-85.55%
NET CHANGE
Cash From Operating Activities	9.050M	12.56M	11.85M
Cash From Investing Activities	-10.69M	-480.0K	-6.820M
Cash From Financing Activities	3.080M	-1.100M	-1.770M
Net Change In Cash	1.440M	10.98M	3.260M
YoY Change	-55.83%	1514.71%	-125.31%
FREE CASH FLOW
Cash From Operating Activities	$9.050M	$12.56M	$11.85M
Capital Expenditures	-$370.0K	-$400.0K	-$560.0K
Free Cash Flow	$9.420M	$12.96M	$12.41M
YoY Change	-24.09%	167.22%	238.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20260695
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	315000
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2323000
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Trading Symbol TradingSymbol	INGN
	dei	Entity Registrant Name EntityRegistrantName	Inogen Inc
	dei	Entity Central Index Key EntityCentralIndexKey	0001294133
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	16793000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66106000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	27000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7801000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	573000
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-11000
CY2015Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1226000
	us-gaap	Sales Revenue Net SalesRevenueNet	84682000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	66000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-215000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-167000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3683000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11410000
	us-gaap	Net Income Loss NetIncomeLoss	7727000
	us-gaap	Interest Expense InterestExpense	18000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-24000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-51000
CY2016Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	43454000
CY2016Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	39793000
CY2015Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	6725000
CY2015Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5155000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5404000
CY2016Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5272000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10290000
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	16000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	43000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7727000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19303057
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20690499
	us-gaap	Cost Of Services Depreciation CostOfServicesDepreciation	8929000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	118150000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2343000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	701000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1001000
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	129922000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1055000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4600000
	ingn	Gain Loss On Write Off Of Rental Units And Other Fixed Assets GainLossOnWriteOffOfRentalUnitsAndOtherFixedAssets	-891000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	224000
	ingn	Provision For Sales Returns And Doubtful Accounts ProvisionForSalesReturnsAndDoubtfulAccounts	8177000
	ingn	Health Care Organization Patient Service Revenue Adjustments HealthCareOrganizationPatientServiceRevenueAdjustments	7783000
	us-gaap	Inventory Write Down InventoryWriteDown	141000
	us-gaap	Inventory Write Down InventoryWriteDown	131000
	us-gaap	Share Based Compensation ShareBasedCompensation	5404000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5950000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25812000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	600000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-546000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9220000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	42000
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	1424000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1856000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-37000
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	25852000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	26321000
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	20799000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	112000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5420000
	us-gaap	Effect Of Exchange Rate On Cash Continuing Operations EffectOfExchangeRateOnCashContinuingOperations	8000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	19903000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56836000
	us-gaap	Interest Paid InterestPaid	9000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-533000
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition, inventory and rental asset valuations and write-downs, accounts receivable allowances for bad debts, returns and adjustments, stock compensation expense, impairment assessments, depreciation and amortization, income tax provision and uncertain tax positions, fair value of financial instruments, and fair values of acquired intangibles. Actual results could differ from these estimates.</p></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications have been made to prior years’ financial statements to conform to current period financial statements’ presentation with no effect on previously reported financial position, results of operations or cash flows. These changes consisted of reclassifications to certain line items in the accompanying Statement of Cash Flows and did not change total operating, financing or investing activities as previously reported. </p></div>
CY2016Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	14497000
CY2015Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	7097000
CY2016Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2162000
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1679000
CY2016Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	160000
CY2015Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	128000
	ingn	Patients Using Portable Oxygen Concentrators PatientsUsingPortableOxygenConcentrators	0.08
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	15081000
CY2016Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	7250000
CY2015Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	52164000
CY2016Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	36625000
CY2015Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	26017000
CY2016Q3	ingn	Doubtful Accounts DoubtfulAccounts	1192000
CY2015Q4	ingn	Doubtful Accounts DoubtfulAccounts	1664000
CY2016Q3	ingn	Rental Revenue Adjustments RentalRevenueAdjustments	5137000
CY2015Q4	ingn	Rental Revenue Adjustments RentalRevenueAdjustments	4115000
CY2016Q3	ingn	Allowances For Sales Returns AllowancesForSalesReturns	579000
CY2015Q4	ingn	Allowances For Sales Returns AllowancesForSalesReturns	366000
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6908000
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6145000
CY2016Q3	ingn	Percentage Of Non Us Revenue Invoiced In Euros PercentageOfNonUSRevenueInvoicedInEuros	0.728
CY2015Q3	ingn	Percentage Of Non Us Revenue Invoiced In Euros PercentageOfNonUSRevenueInvoicedInEuros	0.875
	ingn	Percentage Of Non Us Revenue Invoiced In Euros PercentageOfNonUSRevenueInvoicedInEuros	0.707
	ingn	Percentage Of Non Us Revenue Invoiced In Euros PercentageOfNonUSRevenueInvoicedInEuros	0.746
CY2016Q3	us-gaap	Property Plant And Equipment Salvage Value PropertyPlantAndEquipmentSalvageValue	0
CY2016Q3	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	497000
CY2015Q3	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	686000
	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1930000
	us-gaap	Cost Of Property Repairs And Maintenance CostOfPropertyRepairsAndMaintenance	1897000
CY2016Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3388000
CY2015Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3539000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10217000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10404000
CY2016Q3	ingn	Rental Equipment Allowance RentalEquipmentAllowance	600000
CY2015Q4	ingn	Rental Equipment Allowance RentalEquipmentAllowance	850000
CY2016Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2016Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2015Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21000
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	73000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1344000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1232000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1076000
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1003000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	28000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	101000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	86000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	33000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9000
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	11000
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10214000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7448000
CY2016Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	7570000
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3548000
CY2016Q3	ingn	Accrued Purchasing Card Liability AccruedPurchasingCardLiability	2000000
CY2015Q4	ingn	Accrued Purchasing Card Liability AccruedPurchasingCardLiability	1581000
CY2016Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	32000
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	45000
CY2016Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	894000
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	245000
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	15122
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	15102
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	943037
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1339775
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	937478
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1372340
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	663175
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	627688
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1284424
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	629136
CY2016Q3	us-gaap	Line Of Credit LineOfCredit	0
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2016Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	80000
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	80000
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.366
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.267
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.351
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.323
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2295370
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	672998
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	424462
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	44636
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	515
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2498755
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1039364
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2390297
	ingn	Share Based Compensation Arrangement By Share Based Payment Award Per Share Price Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardPerSharePriceExpired	8.70
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.36
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	44.47
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.84
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	27.99
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.70
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	27.41
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	270000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4797000
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	11579000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	291000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1169000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1157000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1155000
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	755000
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	263000
CY2015Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	221000
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	15.63
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	27.18
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y11M23D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y2M5D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y7M17D
CY2015	ingn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare	21.07
	ingn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare	32.49
CY2016Q3	ingn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue	44.27
CY2016Q3	ingn	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue	32.72
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1953000
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1016000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5404000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2343000
	ingn	Share Based Compensation Expense Reduced Rate For Estimated Forfeiture ShareBasedCompensationExpenseReducedRateForEstimatedForfeiture	0.073
	ingn	Share Based Compensation Expense Reduced Rate For Estimated Forfeiture ShareBasedCompensationExpenseReducedRateForEstimatedForfeiture	0.075
CY2016Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	17607000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	766000
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	661000
CY2016Q3	us-gaap	Purchase Obligation PurchaseObligation	40200000
CY2015Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1973000
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1115000
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	2367000
CY2015	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1871000
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	318000
CY2015	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	510000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1261000
CY2015	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1523000
CY2016Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3397000
CY2016Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	250000
CY2016Q3	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	1250000
CY2016Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	980000
CY2016Q3	ingn	Number Of Contract Designated Hedges NumberOfContractDesignatedHedges	14
CY2016Q3	ingn	Number Of Contract Non Designated Hedges NumberOfContractNonDesignatedHedges	4

Files In Submission

Name	View Source	Status
0001564590-16-027375-index-headers.html	Edgar Link	pending
0001564590-16-027375-index.html	Edgar Link	pending
0001564590-16-027375.txt	Edgar Link	pending
0001564590-16-027375-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ingn-10q_20160930.htm	Edgar Link	pending
ingn-20160930.xml	Edgar Link	completed
ingn-20160930.xsd	Edgar Link	pending
ingn-20160930_cal.xml	Edgar Link	unprocessable
ingn-20160930_def.xml	Edgar Link	unprocessable
ingn-20160930_lab.xml	Edgar Link	unprocessable
ingn-20160930_pre.xml	Edgar Link	unprocessable
ingn-ex101_119.htm	Edgar Link	pending
ingn-ex311_157.htm	Edgar Link	pending
ingn-ex312_158.htm	Edgar Link	pending
ingn-ex321_160.htm	Edgar Link	pending
ingn-ex322_159.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INGN
Inogen Inc Stock $ingn

2016 Q3 Form 10-Q Financial Statement

#000156459016027375 Filed on November 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INGN Inogen Inc Stock $ingn

2016 Q3 Form 10-Q Financial Statement

#000156459016027375 Filed on November 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INGN
Inogen Inc Stock $ingn